D-0255-2022 Class III Terminated

Recalled by UNICHEM PHARMACEUTICALS USA INC — East Brunswick, NJ

FDA drug recall D-0255-2022 was initiated by UNICHEM PHARMACEUTICALS USA INC on Oct 25, 2021 and is designated Class III. Reason for recall: Discoloration The recall status is terminated (terminated Oct 12, 2022). Affected quantity: 1284 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 1, 2021
Initiation Date
Oct 25, 2021
Termination Date
Oct 12, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1284 bottles

Product description

Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Area. Meerut Road, Ghaziabad -201 003, India. Manufactured for: Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ 06815, NDC 29300-116-05.

Reason for recall

Discoloration

Distribution pattern

Nationwide within the United States

Code information

Lot #: ZTPM20044, Exp. Date 09/30/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0255-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0255-2022. Report a data issue: hello@regdatalab.com.